Pedro A. S.
- Country
- Spain
- Department
- Pediatric
Research Overview
- Evaluation of INZ-701 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Infants with ENPP1 or ABCC6 Deficiency
- Phase 3 Evaluation of INZ-701 Efficacy and Safety in Pediatric Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Deficiency
- Phase 3 Evaluation of INZ-701 for Efficacy and Safety in Infants with Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Deficiency
Data & Insights
Has run more than one trial at 1 of 6 partner sites.
Specializations
Metabolic Disorders
This investigator specializes in studying rare genetic disorders affecting metabolic processes, with particular focus on ENPP1 Deficiency and ABCC6 Deficiency. Their research explores innovative therapeutic approaches for these challenging metabolic conditions.
- Enzyme Deficiency Disorders
- Genetic Metabolic Conditions
- Rare Disease Research
The investigator's work involves evaluating novel therapeutic agents targeting these specific enzymatic pathways.
Pediatric Medicine
Specialized in treating infant metabolic disorders, the investigator focuses on developing therapeutic interventions for young patients with genetic enzyme deficiencies. Their research aims to address early-onset manifestations of these conditions.
- Infant Medical Care
- Pediatric Metabolic Disorders
- Early Intervention Strategies
Their work emphasizes understanding treatment responses in pediatric populations with rare genetic conditions.
Clinical Pharmacology
The investigator studies pharmacokinetics and pharmacodynamics of novel therapeutic agents, particularly in the context of rare genetic disorders. Their expertise includes evaluating drug safety and tolerability profiles in vulnerable populations.
- Drug Safety Assessment
- Therapeutic Monitoring
- Clinical Response Evaluation
Their research involves careful assessment of treatment responses and safety parameters in specialized patient populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.